Connect with us at CPHI Worldwide 2025

Leverage our 50 years of experience and integrated CDMO solutions for the success of your project

At Rentschler Biopharma, reliability you can trust is more than a promise—it's our commitment. As a global leader in CDMO services for biopharmaceuticals, including advanced therapies, we take pride in our contributions to nearly 25% of FDA-approved biopharmaceuticals in 2023. 

 

Schedule a meeting

We are looking forward to seeing you at CPHI Worldwide 2025

Booth: 4, 1M52

Date: October 28-30 2025

Location: Ludwig-Erhard-Anlage 1, 60327 Frankfurt Main , Germany

Connect with our team at the event

Rentschler-Biopharma Benedikt von Braunmühl CEO

Benedikt von Braunmühl

Chief Executive Officer

Rentschler Biopharma Patrick Meyer BD

Dr. Patrick Meyer

Global Head of Business Development

Schedule a meeting

 

Rentschler Biopharma Konstantin Bagnjuk BD

Dr. Konstantin Bagnjuk

Director Business Development

Schedule a meeting

 

Marine Maestracci-Roubille

Marine Maestracci-Roubille

Head of ATMP Business Development

Schedule a meeting

 

Rentschler Biopharma Susanne Gulden BD

Dr. Susanne Gulden

Director Business Development

Schedule a meeting

 

Rentschler Biopharma Katarzyna Tkocz BD

Katarzyna Tkocz

Director Alliance Management

Schedule a meeting

 

Discover our Service Portfolio

We offer integrated CDMO solutions for biologics customized to your needs - from process development to clinical and commercial manufacturing. 

Press and Media Requests

Our Communications Team is happy to answer your questions and give you updates about the latest developments at our company.

Rentschler Biopharma news Latika Bhonsle-Deeng

Dr. Latika Bhonsle-Deeng

Global Head of Communications

E-Mail

 

Get in Touch with our Business Development Team

Are you interested in learning more? We look forward to hearing from you.

*Erforderliche Felder